Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Highlights from the 2012 NCID Meeting

Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Highlights from the 2012 NCID Meeting ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
23 Jul 2012

International Network of bio-banks and expert centres

Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz, Austria
International Network of bio-banks and expert centres ( Prof Kurt Zatloukal – Institute of Pathology, Medical University of Graz, Austria )
23 Jul 2012

The impact of breast cancer in Africa

Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria
The impact of breast cancer in Africa ( Dr Clement Adebamowo – Institute of Human Virology, Abuja, Nigeria )
20 Jul 2012

Landscape of cancer care in Bangladesh

Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh
Landscape of cancer care in Bangladesh ( Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh )
20 Jul 2012

Circulating metastasis-initiating cells in breast cancer

Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany
Circulating metastasis-initiating cells in breast cancer ( Prof Andreas Trumpp - German Cancer Research Centre (DKFZ), Heidelberg, Germany )
19 Jul 2012

The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy

Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA
The ceRNA Hypothesis and the non-coding revolution in cancer research and therapy ( Prof Pier Paolo Pandolfi - Harvard Medical School, Boston, USA )
19 Jul 2012

Understanding the mechanisms of breast cancer resistance

Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands
Understanding the mechanisms of breast cancer resistance ( Prof Jos Jonkers – Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jul 2012

Translational and tailored, but can we afford it?

Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden
Translational and tailored, but can we afford it? ( Prof Ulrik Ringborg - Karolinska Institute, Stockholm, Sweden )
17 Jul 2012

The immuno side of melanoma

Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA
The immuno side of melanoma ( Dr Antoni Ribas – UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA )
16 Jul 2012

Constructing successful biomarker clinical trials

Dr Lisa McShane – National Cancer Institute, Bethesda, USA
Constructing successful biomarker clinical trials ( Dr Lisa McShane – National Cancer Institute, Bethesda, USA )
16 Jul 2012

Highlights of the 22nd EACR meeting and tackling glioblastoma

Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain
Highlights of the 22nd EACR meeting and tackling glioblastoma ( Dr Joan Seoane – Vall d’Hebron Institute of Oncology, Spain )
16 Jul 2012

The changing field of drug development

Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly
The changing field of drug development ( Dr Jonathan Yingling – Oncology Drug Discovery, Eli Lilly )
16 Jul 2012